Comprehensive Study Guide on Iron Metabolism and Related Clinical Pathology
General Properties and Chemical States of Iron
Iron is established as the most abundant transition metal found within the human body. As an essential mineral, it is not produced endogenously and must be acquired through the diet. A normal daily diet typically contains approximately of iron, though the body only absorbs between and of this total. This absorption occurs primarily in the duodenum and the upper jejunum. Conceptually, iron distribution in the body is managed across three distinct functional compartments.
The chemical state of iron determines its physiological utility. Most iron in the body is found within hemoglobin and must remain in the ferrous state, denoted as , to be functional. Ferrous iron is responsible for binding to oxygen to facilitate transport to the lungs and various body tissues. In contrast, the ferric form, denoted as , is unable to bind to hemoglobin. However, ferric iron is the form that binds to the transport protein transferrin. Furthermore, iron is maintained in the ferric () state when it is stored within ferritin.
Storage Forms of Iron: Ferritin and Hemosiderin
Ferritin serves as the primary storage form of iron and is categorized as an acute-phase reactant. It is composed of a protein shell called apoferritin combined with ferric iron. This water-soluble complex features a cage-like structure where the apoferritin protein sequesters the iron. A single molecule of ferritin has the capacity to bind more than iron ions.
Hemosiderin represents the second storage form of iron and is characterized as water-insoluble. It is considered a breakdown product or a degradation form of ferritin. Hemosiderin is found predominantly within the liver, the spleen, and the bone marrow. Clinically, it may be detected in the urine, a condition known as hemosiderinuria. The presence of hemosiderin can be confirmed through the use of Perl’s Prussian blue stain.
Iron Kinetics: Intake and Epithelial Absorption
Iron metabolism begins with the intake of iron from the diet, which provides iron in two forms: heme iron and non-heme iron. Heme iron is sourced from iron incorporated into cells and is easily transported into epithelial cells via a specific heme transporter. Non-heme iron exists in the ferric () state and cannot enter epithelial cells directly. For absorption to occur, ferric iron must be reduced to the ferrous () state by the action of the enzyme cytochrome b. Once reduced, it enters the epithelial cell through the divalent metal transporter-1, abbreviated as .
Once inside the intestinal epithelial cells, iron can be stored in the lumen as mucosal ferritin. This mucosal iron is confined to the epithelial cell and is eventually lost during the process of defecation or through the natural shedding of the intestinal epithelium. Iron that is not stored is transported out of the cell into the blood circulation by a protein called ferroportin. Before it can enter the circulation and bind to transport proteins, the ferrous iron must be oxidized back into the ferric () state. This conversion is facilitated by the enzyme hephaestin.
Circulation, Transport, and Transferrin Dynamics
Upon entering the blood circulation, ferric iron is taken up and carried throughout the body by transferrin. Transferrin acts as a transport vehicle, often compared to a bus with occupied and empty seats. Under normal physiological conditions, iron occupies only about of the available binding sites on transferrin. The empty spaces that remain available for binding denote the Total Iron Binding Capacity, or . There is an inverse relationship between the amount of iron currently bound and the ; the more empty spaces available to take up iron, the higher the value of the .
Transferrin circulates through the blood to deliver iron to various sites of need. It travels to the bone marrow to provide iron for hemoglobin formation. It also travels to the liver, which serves as a sensory hub for iron levels. If the liver detects that transferrin is nearly saturated, it interprets this as a signal that the blood does not require more iron. In response, the liver produces hepcidin to block ferroportin, thereby preventing ferrous iron from exiting the intestinal epithelial cells and entering the bloodstream.
Iron Destinations: Bone Marrow, Spleen, and Liver
The bone marrow is a primary destination for iron, especially during erythropoiesis. Transferrin releases iron into the bone marrow for incorporation into hemoglobin synthesis. This process specifically initiates during the basophilic normoblast stage of red blood cell development. Since iron is the central structure of the hemoglobin molecule, its availability is crucial for the marrow to release mature red blood cells into circulation.
The spleen serves as the destination for senescent or old red blood cells, which typically have a lifespan of approximately days. Through the process of extravascular hemolysis, the spleen facilitates the destruction of these old cells via macrophages. This destruction releases iron, which is then captured by transferrin for reuse. This recycled iron is carried back to the bone marrow, creating a continuous cycle of iron utilization.
The liver acts as a major storage site for iron. Transferrin transports iron to the liver, where it is deposited in the form of ferritin and hemosiderin. This ensures a reservoir of iron is available for the body's future needs.
Systemic Regulation by Hepcidin
Hepcidin is a peptide hormone produced by hepatocytes in the liver and serves as the master regulator of systemic iron metabolism. It controls systemic iron levels by binding to ferroportin, which is the only known cellular iron exporter. Ferroportin is located on the surfaces of enterocytes in the intestine, macrophages that recycle iron from old red blood cells, and hepatocytes. When hepcidin binds to ferroportin, it triggers the internalization and degradation of the exporter, effectively reducing the amount of iron that enters the bloodstream.
The production of hepcidin is directly proportional to the body's iron stores; as ferritin levels increase, hepcidin production also increases. Conversely, hepcidin levels are inversely proportional to both serum iron and ferroportin activity. High iron storage triggers increased hepcidin, which blocks ferroportin and decreases absorption. Low iron storage leads to decreased hepcidin, allowing ferroportin to remain active and increasing iron absorption. A deficiency in hepcidin can lead to iron overload syndromes such as hereditary hemochromatosis, while overproduction of hepcidin, often seen in chronic inflammation, can result in microcytic anemia, specifically the anemia of chronic disease.
Cellular Iron Release and Recycling Pathways
Iron release from cells requires the protein ferroportin, which is present on the cell surfaces of the gut, liver, and macrophages. This process requires a cofactor to oxidize the iron to allow it to bind to transferrin. In the gut, this cofactor is hephaestin, while in other cells, ceruloplasmin performs this role. Transferrin production in the liver is regulated by iron status: its production decreases during iron overload and increases during iron deficiency, making it a reliable marker for iron status.
Iron recycling is the process by which iron is salvaged from dying cells, particularly senescent red blood cells in the spleen. Macrophages ingest these cells and break down the hemoglobin, storing the iron as ferritin. Ferroportin then exports this iron into the blood, where it binds to apotransferrin. Other salvage pathways involve plasma proteins like haptoglobin, which binds free hemoglobin, and hemopexin, which binds free heme. Both proteins prevent the loss of iron in the urine and deliver their cargo back to the liver to be stored or exported via ferroportin.
Laboratory Assessment: Serum Iron and TIBC
Serum iron measures the amount of iron currently bound to transferrin in the blood. This is typically measured using a colorimetric method where an acid releases iron from transferrin, allowing it to form a colored complex with a reagent like ferrozine, which is then measured spectrophotometrically. Serum iron is highly variable and is affected by diet and diurnal cycles, typically peaking in the morning due to hepcidin fluctuations. Consequently, the standard for testing is a fasting, early morning collection. The typical adult male reference interval is .
Total Iron Binding Capacity () measures the maximum amount of iron that can bind to transferrin, reflecting the total availability of the transport protein. To measure , excess ferric iron is added to saturate all transferrin binding sites, and unbound iron is removed using magnesium carbonate. The remaining bound iron is then measured. High levels generally indicate iron deficiency because the body produces more transferrin to capture scarce iron. Low levels are seen in chronic inflammatory or liver diseases. The typical reference interval is .
Laboratory Assessment: Transferrin Saturation and Ferritin
Percent transferrin saturation indicates the percentage of transferrin's total binding capacity that is currently occupied by iron. The formula for this assessment is . Normally, about one-third of transferrin is saturated, with a reference range of to . A saturation level below to points toward iron deficiency, while levels above to suggest iron overload, such as hemochromatosis.
Ferritin is the intracellular iron-storage protein found primarily in the liver, spleen, and bone marrow. Small amounts are secreted into the plasma by macrophages and are measured as serum ferritin. Serum ferritin levels correlate strongly with total body iron stores, making it a non-invasive alternative to bone marrow staining. However, because it is an acute phase reactant, levels can be falsely elevated during infection, inflammation, or liver disease. The normal reference range is . Levels below are highly diagnostic of iron deficiency, while the zone between and is considered equivocal during illness.
Tissue Staining and Functional Iron Markers
Prussian blue staining is a histochemical technique used to detect ferric iron () in tissues and is considered the gold standard for assessing body iron stores. The reagent, acidic potassium ferrocyanide, reacts with ferric iron to form a dark blue granular complex with the chemical formula . While hemosiderin deposits stain well, ferritin generally does not because it is protected by its protein shell. This stain is typically applied to bone marrow or liver biopsies to provide a semiquantitative score of iron status.
Soluble transferrin receptor () is a truncated form of the receptor shed into the plasma that reflects cellular demand for iron. When intracellular iron is low, cells express more receptors on their surface and release more into the blood. Unlike ferritin, is not affected by inflammation, making it useful for detecting iron deficiency in patients with chronic diseases. Increased indicates either iron deficiency or rapid erythropoiesis, such as in hemolytic anemia. The typical reference interval is .
Specialized Indicators of Erythropoiesis
The hemoglobin content of reticulocytes ( or ) measures the hemoglobin in young, immature red blood cells. Because reticulocytes represent erythropoiesis within the previous hours, this test provides a near real-time indicator of iron availability for red cell production. Low values indicate functional iron deficiency. The reference range is .
The ratio combines two markers to improve diagnostic accuracy, specifically to distinguish between iron deficiency and the anemia of chronic disease. It is particularly useful when ferritin falls into the equivocal zone (). The normal value for this ratio is .
Zinc Protoporphyrin () is formed when zinc replaces iron in the protoporphyrin ring during heme synthesis. This occurs when iron is unavailable. increases in iron deficiency anemia and lead poisoning, the latter being its most significant diagnostic use due to the inhibition of the enzyme ferrochelatase. It is detected by fluorescence and serves as a marker for disrupted iron utilization. The reference interval is less than of red blood cells.
The Thomas Plot for Diagnostic Differentiation
The Thomas Plot is a four-quadrant graph used to differentiate various iron states by plotting the hemoglobin content of reticulocytes on the X-axis and the ratio on the Y-axis. The lower right quadrant indicates True Iron Deficiency, characterized by an increased ratio and decreased reticulocyte hemoglobin. The lower left quadrant indicates Functional Iron Deficiency, where reticulocyte hemoglobin is low but the ratio remains normal. The upper right quadrant signifies Latent Iron Deficiency, showing an increased ratio with normal reticulocyte hemoglobin. Finally, the upper left quadrant represents a Normal Iron Status.
Comparison of Iron Studies in Microcytic Anemias
In Iron Deficiency Anemia, ferritin, serum iron, and transferrin saturation are decreased, while , , and are increased. Bone marrow shows no stainable iron. In -thalassemia Minor, ferritin and serum iron are typically normal to increased, is normal, and hemoglobin is increased. In the Anemia of Chronic Inflammation, ferritin is normal to increased, but serum iron and are decreased, and remains normal. Sideroblastic Anemia is characterized by increased ferritin and serum iron, with ringed sideroblasts visible in the bone marrow. Lead Poisoning presents with variable serum iron, normal , and a marked increase in , along with increased aminolevulinic acid () in the urine.
Pathological Iron States: Deficiency and Overload
Iron deficiency is an extremely common condition resulting from reduced intake, increased loss, or increased demand. It is noted that iron deficiency is not a primary diagnosis but a manifestation of an underlying cause, such as obstetric factors, malabsorption, bowel cancer, hemorrhoids, or inflammatory bowel disease. Internally, iron stores are depleted before clinical deficiency is observed. Laboratory indicators include low ferritin, elevated , low transferrin saturation, hypochromia, and microcytosis.
Iron overload can manifest as hemosiderosis or hemochromatosis. Hemosiderosis is characterized by increased iron storage in tissues as hemosiderin without immediate tissue damage, though it may progress. Hereditary Hemochromatosis, also known as "Bronzed Diabetes," is an autosomal recessive genetic disorder causing gastrointestinal iron absorption to be to times the normal rate. This leads to progressive iron accumulation and damage to organs. The skin may take on a bronze or golden color due to hemosiderin deposits. Excess iron can cause cardiomyopathy and congestive heart failure in the heart, and it significantly increases the risk of hepatocellular carcinoma in the liver. Cellular damage is often the result of oxidative stress caused by excess iron.